marked shift to the left. Peripheral smear showed innumerable platelets (figure 1).
ESR and CRP were elevated. Her blood urea, creatinine, fasting blood sugar, fasting lipid profile, electrolytes, serum transaminases and TSH were within normal range. Alkaline phosphatase was mildly raised at 156 U/L, but serum iron, TIBC and % saturation were normal.
Her chest X-ray showed left sided pleural effusion. ECG was normal. Ultrasonography of abdomen showed mild splenomegaly, few enlarged lymph nodes at porta hepatis, minimal ascites and left sided pleural effusion. Her Mantoux test was negative. Sputum examination did not reveal any AFB. She was non-reactive for HIV-1 & 2 antibodies.
Bone marrow examination revealed myeloid h y p e r p l a s i a a n d s e v e r e m e g a k a r y o c y t i c hyperplasia. Stainable iron was present in marrow. JAK2 V617F mutation was not detected and karyotyping was normal. Bone marrow sample was sent for mycobacterial culture, which later did not show any growth.
FNAC from the cervical lymph node was consistent with tubercular lymphadenitis. The pleural fluid study revealed an exudative effusion.
A diagnosis of "disseminated tuberculosis with reactive thrombocytosis and leucocytosis" was made and the lady was initiated on anti-tubercular therapy (ATT) with Rifampicin (R), Isoniazid (H), Ethambutol (E) and Pyrazinamide (Z) for 2 months followed by RH for another 4 months along with treatment for hypertension. The lady was afebrile by 2nd week of therapy. Her TLC, Hb, platelet count and liver enzymes were monitored weekly for initial one month and monthly thereafter. Her TLC and platelet count started decreasing by 3rd week of ATT. TLC, DLC and platelet counts became normal by 5th month of ATT. Her blood pressure was controlled on telmisartan 40 mg daily. She gained 4 kg weight at the end of six months of ATT.
Discussion
Haematological changes in disseminated tuberculosis are varied. Pancytopaenia, leukoerythroblastic anaemia, thrombocytopaenia, m a r k e d t h r o m b o c y t o s i s , n e u t r o p h i l i a , monocytopaenia, monocytosis and anaemias of different types have been described [1, 2, 3] . Thrombocytosis and leucocytosis have been associated with tuberculosis but are uncommon findings. Chakrabarti et al have found thrombocytopaenia and leucopaenia to be much more common than thrombocytosis -single case [4] . Baynes et al found 9% patients with tuberculosis 9 having thrombocytosis >1000 x10 /L [5] .
The pathogenesis of thrombocytosis in tuberculosis is not clear. It has variously been attributed to increased thrombopoietin [6] or production of platelets in pulmonary vasculature by fragmenting proplatelets [7] . Even in a diagnosed case of tuberculosis presence of marked thrombocytosis and leukocytosis with shift to the left in the same patient can be a diagnostic dilemma.
Other coexisting haematological conditions like myeloproliferative disorders need to be excluded as case reports of presence of atypical cells in peripheral blood picture have been reported earlier.
Jadhav et al described blast cells with Auer bodies in disseminated tuberculosis [8] . Subramanian et al had reported a case of acute myeloid leukaemia which showed disseminated tuberculosis but no leukaemia on autopsy [9] . Detection of JAK2 V617F mutation and karyotyping may be helpful to exclude coexisting myeloproliferative disorders. Since these tests are not easily available, the clue to the diagnosis of the haematological changes in such cases can be from meticulous physical examination along with different haematological, biochemical and radiological investigation besides response to ATT. Awareness of haematological abnormalities in tuberculosis will also help in diagnosis.
Haematological findings in tuberculosis

Key Points
• Varied haematological manifestations can occur in Tuberculosis.
• Haematological findings can be a diagnostic dilemma.
• Haematological findings should be interpreted taking the entire clinical picture into consideration.
